上海麦角硫因生物科技集团有限公司

Chinese synthetic biology company founded in 2016 in Shanghai and devoted to slowing ageing through biotechnological production of natural anti-ageing active ingredients. Holds world leading capability in enzyme directed evolution and high density fermentation, with patented technology spanning chassis cells, enzyme engineering, high density fermentation and purification and crystallisation, and in 2021 commissioned the world's first industrial scale plant producing ergothioneine by a biological route. Its ergothioneine stands out with purity as high as 99 per cent and optical rotation of at least plus 122 degrees, won the Ringier Innovation Award and a CIC innovative ingredient award in 2022, and in February 2025 its Dr.Ergo ergothioneine became the first Chinese and the world's second ergothioneine product to obtain United States FDA GRAS status, alongside Chinese and European patents, European Union Novel Food approval and Japanese clinical trial validation.